CraniUS LLC is a cutting-edge brand in the field of Neuroplastic and Reconstructive Surgery. Founded in May 2021 by Dr. Chad Gordon in Baltimore, MD, CraniUS aims to revolutionize the treatment of brain diseases through their flagship device, the NeuroPASS.

This innovative device is designed to overcome the challenges presented by the blood-brain barrier, which has limited the effectiveness of traditional therapeutic treatments. CraniUS utilizes a groundbreaking pump design and wireless charging technology to enable long-term and direct administration of medicine via CED (convection-enhanced delivery). This method of medicine delivery was first introduced by the National Institute of Health (NIH).

By focusing on the brain-medicine interface (BMI), CraniUS is at the forefront of delivering neurological medicines directly to the brain, offering new possibilities for treating multiple diseases. Driven by their mission to invent and engineer world-class technology, CraniUS is dedicated to defining the future of diagnostics and treatments for patients with brain disease. They envision becoming a global leader in medical device research and development, particularly in the field of smart, implantable technologies.

CraniUS values passion, pioneering spirit, exceptional engineering solutions, celebrating success, teamwork, and a positive mindset. With their diverse skills and unwavering dedication, the CraniUS team is determined to improve patient outcomes and shape the future of neurosurgery